Abstract

This study compared the cytotoxicity of IQOS aerosols to smoke from Marlboro Red (MR) and 3R4F reference cigarettes. Aerosol/smoke solutions were tested as the gas vapor phase (GVP), particulate phase (total particulate matter or TPM), or whole aerosol/smoke (WA), the latter being what smokers actually inhale. Cytotoxicities were evaluated using the LDH, MTT and neutral red uptake (NRU) assays in conjunction with eight different cell types, mainly from the respiratory system. Most test solutions did not compromise the plasma membranes of cells (LDH). However, mitochondrial activity (MTT) and dye uptake/lysosomal activity (NRU) were equally depressed by IOQS aerosols and cigarette smoke solutions at the high concentrations. Our NRU data with mouse NIH/3T3 transformed fibroblasts were similar to those previously reported by the IQOS manufacturer and showed little cytotoxicity in the NRU assay. In both studies with NIH/3T3 cells, the results were significantly different from 3RF4 cigarette smoke, suggesting reduced toxicity with IQOS. However, by expanding evaluations to a broader spectrum of cells that included respiratory system cells and by including higher concentrations of GVP, as well as WA, cytotoxicity equivalent to that of Marlboro Red and 3R4F cigarettes was frequently observed with IQOS aerosols in the MTT and NRU assays.

Highlights

  • IQOS is a novel heat-not-burn cigarette or heated tobacco product released by Phillip Morris International (PMI) in 2014

  • The cytotoxicities of conventional cigarette smoke and IQOS aerosols were compared in a comprehensive screen using eight cell types, three endpoint assays, and various components of smoke/aerosols

  • Additional cells from respiratory tissue were included as relevant models for inhalation toxicology, and H9 human embryonic stem cells (H9-hESC) were studied to determine how embryos and prenatal development may be affected by IQOS

Read more

Summary

Introduction

IQOS is a novel heat-not-burn cigarette or heated tobacco product released by Phillip Morris International (PMI) in 2014. Marketed as a harm reduction product, there is currently little published data on the health effects of IQOS aerosol. A filter was used to separate the gas vapor phase (GVP), which passed through the filter, from total particulate matter (TPM). The GVP was captured in phosphate-buffered saline solution, while the TPM was captured on the filter and solubilized in dimethyl sulfoxide (DMSO) [4]. IQOS aerosols were tested for cytotoxicity on mouse embryonic fibroblasts (NIH/3T3) using the neutral red uptake assay (NRU). From these data, it was concluded that IQOS aerosols were less cytotoxic than 3R4F reference cigarettes

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call